Skip to main content
. 2021 Aug 14;5(9):1033–1040. doi: 10.1002/jgh3.12627

Table 2.

Patient‐reported current prescription medication for their ulcerative colitis (UC) and satisfaction with medication

Patients in remission Current overall health
Overall Male Female Yes No Excellent/good Fair/poor
Current prescription medication, n (%)
Biologic 21 (37) 15 (71) 6 (29) 15 (71) 6 (29) 8 (38) 13 (62)
Immunosuppressant 19 (33) 12 (63) 7 (37) 10 (53) 8 (42) 5 (26) 14 (74)
5‐aminosalicylates 12 (22) 6 (50) 6 (50) 8 (67) 4 (33) 4 (33) 8 (67)
Corticosteroid 17 (29) 9 (53) 8 (47) 9 (53) 7 (41) 3 (19) 13 (81)
Satisfaction with current prescription medication, n (%)
Very satisfied 15 (28) 10 (67) 5 (33) 11 (73) 4 (27) 6 (40) 9 (60)
Somewhat satisfied 34 (64) 21 (62) 13 (38) 21 (64) 12 (36) 9 (27) 24 (73)
Somewhat dissatisfied 3 (6) 1 (33) 2 (67) 1 (33) 2 (67) 0 (0) 3 (100)
Very dissatisfied 1 (2) 1 (100) 0 (0) 1 (100) 0 (0) 0 (0) 1 (100)
Top reasons for satisfaction, n (%)
Less frequent flares 26 (54) 15 (58) 11 (42) 17 (65) 9 (35) 8 (31) 18 (69)
Less abdominal pain 23 (47) 13 (57) 10 (43) 15 (65) 8 (35) 7 (30) 16 (70)
Less urgency to visit the bathroom 22 (45) 13 (59) 9 (41) 15 (68) 7 (32) 8 (36) 14 (64)

Remission was self‐reported by patients and was defined as disease being controlled with few to no symptoms.

Patients could select more than one answer.

Overall current prescription medication: other (n = 3; 6%) and none (n = 4; 7%), data not shown.